BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22072718)

  • 1. Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis.
    Niture SK; Jaiswal AK
    J Biol Chem; 2011 Dec; 286(52):44542-56. PubMed ID: 22072718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.
    Niture SK; Jaiswal AK
    Cell Death Differ; 2011 Mar; 18(3):439-51. PubMed ID: 20865015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothymosin-alpha mediates nuclear import of the INrf2/Cul3 Rbx1 complex to degrade nuclear Nrf2.
    Niture SK; Jaiswal AK
    J Biol Chem; 2009 May; 284(20):13856-13868. PubMed ID: 19279002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant-induced INrf2 (Keap1) tyrosine 85 phosphorylation controls the nuclear export and degradation of the INrf2-Cul3-Rbx1 complex to allow normal Nrf2 activation and repression.
    Kaspar JW; Niture SK; Jaiswal AK
    J Cell Sci; 2012 Feb; 125(Pt 4):1027-38. PubMed ID: 22448038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial phosphatase PGAM5 regulates Keap1-mediated Bcl-xL degradation and controls cardiomyocyte apoptosis driven by myocardial ischemia/reperfusion injury.
    Yang C; Liu X; Yang F; Zhang W; Chen Z; Yan D; You Q; Wu X
    In Vitro Cell Dev Biol Anim; 2017 Mar; 53(3):248-257. PubMed ID: 27815660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria.
    Lo SC; Hannink M
    Exp Cell Res; 2008 May; 314(8):1789-803. PubMed ID: 18387606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90 interaction with INrf2(Keap1) mediates stress-induced Nrf2 activation.
    Niture SK; Jaiswal AK
    J Biol Chem; 2010 Nov; 285(47):36865-75. PubMed ID: 20864537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance.
    Niture SK; Jaiswal AK
    Free Radic Biol Med; 2013 Apr; 57():119-31. PubMed ID: 23275004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex.
    Lo SC; Hannink M
    J Biol Chem; 2006 Dec; 281(49):37893-903. PubMed ID: 17046835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients.
    Cheng J; Qian D; Ding X; Song T; Cai M; Dan Xie ; Wang Y; Zhao J; Liu Z; Wu Z; Pang Q; Zhu L; Wang P; Hao X; Yuan Z
    Cell Death Dis; 2018 Sep; 9(10):991. PubMed ID: 30250224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autoregulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance.
    Kaspar JW; Jaiswal AK
    J Biol Chem; 2010 Jul; 285(28):21349-58. PubMed ID: 20452971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGAM5 exacerbates acute renal injury by initiating mitochondria-dependent apoptosis by facilitating mitochondrial cytochrome c release.
    Li JY; Sun XA; Wang X; Yang NH; Xie HY; Guo HJ; Lu L; Xie X; Zhou L; Liu J; Zhang W; Lu LM
    Acta Pharmacol Sin; 2024 Jan; 45(1):125-136. PubMed ID: 37684381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 signaling and cell survival.
    Niture SK; Kaspar JW; Shen J; Jaiswal AK
    Toxicol Appl Pharmacol; 2010 Apr; 244(1):37-42. PubMed ID: 19538984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothymosin-α mediates nuclear import of the INrf2/Cul3·Rbx1 complex to degrade nuclear Nrf2.
    Niture SK; Jaiswal AK
    J Biol Chem; 2016 Jan; 291(3):1199. PubMed ID: 26773126
    [No Abstract]   [Full Text] [Related]  

  • 15. PGAM5 interacts with Bcl-rambo and regulates apoptosis and mitophagy.
    Hashino T; Matsubara H; Xu J; Tanaka R; Kusagawa E; Ueda Y; Yoshida H; Kataoka T
    Exp Cell Res; 2022 Nov; 420(1):113342. PubMed ID: 36075447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2.
    Kigoshi Y; Fukuda T; Endo T; Hayasaka N; Iemura S; Natsume T; Tsuruta F; Chiba T
    Sci Rep; 2015 Aug; 5():12857. PubMed ID: 26238671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer.
    Chang LC; Fan CW; Tseng WK; Chein HP; Hsieh TY; Chen JR; Hwang CC; Hua CC
    Biomark Med; 2017 Dec; 11(12):1103-1111. PubMed ID: 29053012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic PGAM5 multimers dephosphorylate BCL-xL or FUNDC1 to regulate mitochondrial and cellular fate.
    Ma K; Zhang Z; Chang R; Cheng H; Mu C; Zhao T; Chen L; Zhang C; Luo Q; Lin J; Zhu Y; Chen Q
    Cell Death Differ; 2020 Mar; 27(3):1036-1051. PubMed ID: 31367011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DNA binding domain of p53 is sufficient to trigger a potent apoptotic response at the mitochondria.
    Matissek KJ; Mossalam M; Okal A; Lim CS
    Mol Pharm; 2013 Oct; 10(10):3592-602. PubMed ID: 23968395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer.
    Khatri R; Shah P; Guha R; Rassool FV; Tomkinson AE; Brodie A; Jaiswal AK
    Mol Cancer Ther; 2015 Jul; 14(7):1728-37. PubMed ID: 25976679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.